Glaukos Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAUKOS, and what generic alternatives to GLAUKOS drugs are available?
GLAUKOS has two approved drugs.
There are two US patents protecting GLAUKOS drugs.
There are fifty-two patent family members on GLAUKOS drugs in seven countries and eleven supplementary protection certificates in eight countries.
Drugs and US Patents for Glaukos
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaukos | PHOTREXA | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Glaukos | IDOSE TR | travoprost | IMPLANT;INTRACAMERAL | 218010-001 | Dec 13, 2023 | RX | Yes | Yes | 10,206,813 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Glaukos | IDOSE TR | travoprost | IMPLANT;INTRACAMERAL | 218010-001 | Dec 13, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Glaukos | IDOSE TR | travoprost | IMPLANT;INTRACAMERAL | 218010-001 | Dec 13, 2023 | RX | Yes | Yes | 11,426,306 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Glaukos Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2015171553 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2014150292 | ⤷ Sign Up |
Japan | 6714674 | ⤷ Sign Up |
Japan | 2016511108 | ⤷ Sign Up |
Australia | 2020204427 | ⤷ Sign Up |
European Patent Office | 3785683 | ⤷ Sign Up |
European Patent Office | 3603590 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Glaukos Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1920764 | PA2012017 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127 |
1514548 | PA2014029 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129 |
1920764 | 1290027-0 | Sweden | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST |
1920764 | 2012/033 | Ireland | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN |
1920764 | 12C0045 | France | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127 |
1920764 | SPC/GB12/038 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129 |
1920764 | PA2012017,C1920764 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.